摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 4'-nitro-3'-(trifluoromethyl)oxanilate | 54166-83-5

中文名称
——
中文别名
——
英文名称
ethyl 4'-nitro-3'-(trifluoromethyl)oxanilate
英文别名
ethyl 4'nitro-3'-(trifluoromethyl) oxanilate;4'-Nitro-3'-(trifluormethyl)-oxanilsaeure-ethylester;ethyl 2-[4-nitro-3-(trifluoromethyl)anilino]-2-oxoacetate
ethyl 4'-nitro-3'-(trifluoromethyl)oxanilate化学式
CAS
54166-83-5
化学式
C11H9F3N2O5
mdl
——
分子量
306.198
InChiKey
VSRIIZOEPRQGNM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    101
  • 氢给体数:
    1
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    草酸,一系列口服活性抗过敏药。
    摘要:
    制备了大量的草酸苯甲酸酯和N-杂芳基草酰胺酸酯,并通过大鼠被动皮肤过敏反应(PCA)测试发现具有抗过敏活性。许多草酰苯甲酸酯具有口服活性,最活泼的物种具有芳基2'-氨基甲酰基和3'-甲氧基。酯从草酰胺酯部分水解会导致口服活性下降。
    DOI:
    10.1021/jm00243a014
点击查看最新优质反应信息

文献信息

  • Oxamic acid derivatives
    申请人:American Home Products Corporation
    公开号:US04154961A1
    公开(公告)日:1979-05-15
    Anti-allergic agents of aromatic oxamic acid derivation present the following formula: ##STR1## in which A is a member selected from the group consisting of .alpha.-naphthyl, .beta.-naphthyl, phenyl, 2,6-di-chlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkyl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy (lower)alkoxy, 2-(oxalyloxy) ethoxy, benzyloxy, N-mono- and di-lower alkylamino(lower)alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono and di lower alkylamino, carboxy, lower alkylcarbonyl, carb(lower)alkoxy, phenoxy(lower)alkoxy, and oxalamidophenoxy radicals; And pharmaceutically acceptable salts thereof.
    芳香族羧酸衍生物的抗过敏药物具有以下化学式:##STR1## 其中 A 是从以下组成的成员中选择的:α-萘基、β-萘基、苯基、2,6-二氯苯基和含有1至3个取代基的苯基基团,这些取代基可以独立地选择自以下组成的取代基:低烷基、低硫代烷基、低烷基磺基、低烷氧基、羟基(低)烷氧基、2-(草酰氧基)乙氧基、苄氧基、N-单-和双-低烷基氨基(低)烷氧基、卤素、磺酰胺基、多卤素(低)烷基、氨基甲酰基、N-低烷基氨基甲酰基、硝基、单和双低烷基氨基、羧基、低烷基羰基、氨基(低)羧基、苯氧基(低)烷氧基和草酰胺基苯氧基基团;以及其药用可接受的盐。
  • Pyridyl oxamic acid derivatives and use in the prevention of allergic
    申请人:American Home Products Corporation
    公开号:US04054661A1
    公开(公告)日:1977-10-18
    Anti-allergic agents of aromatic and heterocyclic oxamic acid derivation present the following formula: ##STR1## in which A is a member selected from the group consisting of 2-thiazolyl, 2-pyridyl, 2-pyridyl-N-oxide, 6-(lower)alkyl-2-pyridyl, 3-cyano-2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 2-pyrazinyl, .alpha.-naphthyl, .beta.naphthyl, phenyl, 2,6-dichlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkyl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy(lower)-alkoxy, 2-(lower alkoxy oxalyloxy) ethoxy, benzyloxy, N-mono-and di-lower alkylamino(lower)-alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono-and di-lower alkylamino, phenylazo, carboxy, lower alkylcarbonyl, cyano, carb(lower)alkoxy, phenoxy(lower)alkoxy, lower alkoxyoxalamido and lower alkoxyoxalamidophenoxy radicals; B, when taken alone, is a member selected from the group consisting of --OH, lower alkoxy, --NH.sub.2, --NHOH, cyclohexyloxy and phenoxy; and Y is a member selected from the group consisting of oxygen and when taken with B and the carbon atom to which they are attached, forms the moiety ##STR2##
    芳香族和杂环氧酰胺衍生的抗过敏剂具有以下公式:##STR1## 其中A是从2-噻唑基,2-吡啶基,2-吡啶基-N-氧化物,6-(较低)烷基-2-吡啶基,3-氰基-2-吡啶基,3-吡啶基,4-吡啶基,2-吡嘧啶基,2-吡嗪基,α-萘基,β-萘基,苯基,2,6-二氯苯基和取代苯基中选择的一种成员,所述取代苯基包含一个到三个取代基,所述取代基独立地选择自较低烷基,较低硫代烷基,较低磺代烷基,较低烷氧基,羟基(较低)-烷氧基,2-(较低烷氧基氧乙酰氧基)乙氧基,苄氧基,N-单和二-较低烷基氨基(较低)-烷氧基,卤,磺酰胺,多卤(较低)烷基,氨基甲酰,N-较低烷基氨基甲酰,硝基,单和二-较低烷基氨基,苯基偶氮,羧基,较低烷基羰基,氰基,羰基(较低)烷氧基,苯氧基(较低)烷氧基,较低烷氧基草酰胺基和较低烷氧基草酰胺基苯氧自由基;B,单独时,是从-OH,较低烷氧,-NH.sub.2,-NHOH,环己氧基和苯氧基中选择的一种成员;Y是从氧中选择的一种成员,当与B和它们连接的碳原子一起被选取时,形成如下部分:##STR2##
  • Oxamic acid derivatives for the prevention of immediate type
    申请人:American Home Products Corporation
    公开号:US03966965A1
    公开(公告)日:1976-06-29
    Anti-allergic agents of ##EQU1## and heterocyclic oxamic acid derivation present the following formula: IN WHICH A is a member selected from the group consisting of 2-thiazolyl, 2-pyridyl, 2-pyridyl-N-oxide, 6-(lower)alkyl-2-pyridyl, 3-cyano-2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidinyl, 2-pyrazinyl, .alpha.-naphthyl, .beta.-naphthyl, phenyl, 2,6-dichlorophenyl, and substituted phenyl moieties containing from one to three substituents in any of the 2,3,4 and 5 positions of the phenyl ring, independently selected from the group consisting of lower alkyl, lower alkylthio, lower alkylsulfinyl, lower alkoxy, hydroxy(lower)-alkoxy, 2-(lower alkoxy oxalyloxy) ethoxy, benzyloxy, N-mono-and di-lower alkylamino(lower)-alkoxy, halo, sulfamyl, polyhalo(lower)alkyl, carbamyl, N-lower alkylcarbamyl, nitro, mono- and di-lower alkylamino, phenylazo, carboxy, lower alkylcarbonyl, cyano, carb(lower)alkoxy, phenoxy(lower)alkoxy, lower alkoxyoxalamido and lower alkoxyoxalamidophenoxy radicals; B, when taken alone, is a member selected from the group consisting of -OH, lower alkoxy, --NH.sub.2, --NHOH, cyclohexyloxy and phenoxy; and Y is a member selected from the group consisting of oxygen and when taken with B and the carbon atom to which they are attached, forms the moiety ##EQU2##
    ##EQU1##的抗过敏剂和杂环氧酰胺衍生物具有以下公式:其中A是从2-噻唑基,2-吡啶基,2-吡啶-N-氧化物,6-(较低)烷基-2-吡啶基,3-氰基-2-吡啶基,3-吡啶基,4-吡啶基,2-吡嘧啶基,2-吡啶基,α-萘基,β-萘基,苯基,2,6-二氯苯基和取代苯基等组成的群中选择的成员,其中该苯环的2,3,4和5位置中的任意位置都包含从一个到三个取代基的取代基,这些取代基独立地从较低烷基,较低硫代烷基,较低磺酰基,较低烷氧基,羟基(较低)-烷氧基,2-(较低烷氧基氧代羰基)乙氧基,苄氧基,N-单和二-较低烷基氨基(较低)-烷氧基,卤素,磺酰基,多卤代(较低)烷基,氨基甲酰基,N-较低烷基氨基甲酰基,硝基,单和双-较低烷基氨基,苯基偶氮基,羧基,较低烷基羰基,氰基,羰基(较低)烷氧基,苯氧基(较低)烷氧基,较低烷氧氧代草酰胺基和较低烷氧氧代草酰胺苯氧基自由基;B,当单独取时,是从-OH,较低烷氧基,-NH.sub.2,-NHOH,环己氧基和苯氧基等组成的群中选择的成员;Y是从氧中选择的成员,当与B和它们连接的碳原子一起取时,形成上述公式。
  • US3966965A
    申请人:——
    公开号:US3966965A
    公开(公告)日:1976-06-29
  • US4036837A
    申请人:——
    公开号:US4036837A
    公开(公告)日:1977-07-19
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物